INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 10/21/2024 at 14:30, 30 days 23 hours ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 month 6 days ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs
PRESS RELEASE

published on 10/14/2024 at 19:45, 1 month 6 days ago

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
Inventiva announces the availability of a prospectus for financing through the issuance of shares and warrants. The AMF approved the prospectus on October 14, 2024

Warrants Shares Financing Prospectus Inventiva
BRIEF

published on 08/30/2024 at 11:04, 2 months 22 days ago

UBS Group AG Crosses Threshold in INVENTIVA Capital

AMF Threshold Crossing Transfer Of Shares Inventiva UBS Group AG
BRIEF

published on 07/31/2024 at 22:05, 3 months 20 days ago

Inventiva Reports Preliminary 2024 First-Half Financial Information

Financial Results Revenue Inventiva H1 2024 R&D Expenses
PRESS RELEASE

published on 07/31/2024 at 22:00, 3 months 20 days ago

Inventiva Reports Preliminary 2024 First-Half Financial Information¹
Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones

Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
BRIEF

published on 07/25/2024 at 22:05, 3 months 26 days ago

Inventiva Secures Patent in Japan for Lanifibranor

Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
PRESS RELEASE

published on 07/25/2024 at 22:00, 3 months 26 days ago

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication

Patent Japan Inventiva Lanifibranor Cirrhosis
BRIEF

published on 07/23/2024 at 10:56, 3 months 29 days ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
BRIEF

published on 07/18/2024 at 08:35, 4 months 3 days ago

Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros

Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates

Accesswire

Published on 11/21/2024 at 14:15, 13 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 28 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 28 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 28 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 28 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 12 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 13 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 28 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 13 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 53 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 30 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 8 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 43 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 43 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE